Clinical trial to compare availability in the body of the active substance nicotine as well as patch adhesion of the newly developed patch LTS Nicotine TTS vs. Nicotinell® (21 mg/24 h) in healthy smokers after single patch application

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-503548-14-00

Acronym

LTS 01/23

Enrollment

Registered

2023-05-22

Start date

2024-09-30

Completion date

2024-11-15

Last updated

2024-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bioequivalence and patch adhesion trial; therapeutical indication not studied

None listed

Sex/Gender

All

Age

18 Years to 64 Years

Germany

None listed

Source: EU CTIS · Data processed: Feb 4, 2026